Seventy-five percent of diabetes trials focused primarily on therapies, while 10% focused on prevention, according to a review in Diabetologia. The global study found 63% of the interventions were drugs, while 12% were behavioral therapies. The core group of participants was 18 and younger in 4% of trials, according to the review.

Full Story:

Related Summaries